BioSpace News Archive

Business

Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

Biogen made a one-time upfront $74 million payment to Skyhawk for research services and an exclusive license to therapeutic candidates for multiple sclerosis, spinal muscular atrophy and other neurological diseases to be developed using Skyhawk’s SkySTAR™ platform

January 4, 2019
·
6 min read
Business

C4 Therapeutics Announces Transformation of Strategic Collaboration to Discover and Develop Degrader-Based Medicines with Roche

C4 Therapeutics announced the transformation of its ongoing research and development partnership with Roche focusing on new cancer treatments based on C4T’s targeted protein degradation technology

January 4, 2019
·
1 min read
Drug Development

KalVista Pharmaceuticals Provides Development Update and 2019 Clinical Plans

KVD900 Phase 2 HAE Trial Data Expected in 2019

January 4, 2019
·
4 min read
Global Portable Oxygen Concentrators Market 2019-2023 | Increasing Number of Product Launches Impacting the Market Growth | Technavio

The global portable oxygen concentrators market 2019-2023 is expected to post a CAGR of close to 11% during the forecast period, according to the latest market research report by Technavio.

January 4, 2019
·
4 min read
Deals

LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical

LifeX CEO Dr. Dietrich Stephan to take over as NeuBase Therapeutics CEO; LifeX names University of Pittsburgh’s Dr. Evan Facher as interim CEO

January 4, 2019
·
2 min read
Deals

Grey Wolf Animal Health Announces the Acquisition of Veterinary Healthcare Solutions Inc.

Strategic acquisition provides national presence to accelerate growth across Canada

January 4, 2019
·
2 min read
Business

Civitas Senior Living Promotes Three More Executives

Elevation of Leadership Indicative of Rapid Growth, Progress

January 4, 2019
·
4 min read
ITC Savlon Celebrates World Braille Day

Introduces its first ever Braille enabled Pack in its portfolio

January 4, 2019
·
3 min read
Job Trends

Heska to Present at J.P. Morgan 2019 Healthcare Conference

Heska Corporation announced that Kevin Wilson, Heska’s President & Chief Executive Officer, will present at the J.P. Morgan 2019 Healthcare Conference on Thursday, January 10, 2019 at 11 a.m. PT in San Francisco, CA.

January 4, 2019
·
2 min read
Deals

MabVax Therapeutics and Oncotelic Enter into Merger Discussions

Divestiture of Selected MabVax Assets Managed by Objective Capital Will Continue

January 4, 2019
·
7 min read